Treatment strategy for reducing the risk of rituximab-induced cytokine release syndrome in patients with intravascular large B-cell lymphoma: a case report and review of the literature

INTRODUCTION: Intravascular large B-cell lymphoma is a rare aggressive disseminated disease characterized by the presence of lymphoma cells in small vessels without lymphadenopathy. Rituximab, a novel monoclonal antibody against the CD20 B-cell antigen, has been reported to be effective in treating...

Descripción completa

Detalles Bibliográficos
Autores principales: Makino, Katsuhiro, Nakata, Jumi, Kawachi, Satoru, Hayashi, Tatsuyuki, Nakajima, Atsuo, Yokoyama, Munehiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3923559/
https://www.ncbi.nlm.nih.gov/pubmed/24377366
http://dx.doi.org/10.1186/1752-1947-7-280

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3923559/
https://www.ncbi.nlm.nih.gov/pubmed/24377366
http://dx.doi.org/10.1186/1752-1947-7-280

Ejemplares similares